Bai L, Sun Y, Li S
Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021.
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Jan;21(1):23-5.
To study alteration of several genes in the process of primary lung cancer.
A series of 59 lung cancer specimens were analyzed for p53, myc oncogene family and mdrl gene by DNA/PCR sequencing, immunohistochemistry and RT-PCR methods.
p53 mutation or/and protein accumulation were found in 37 of 57(65%) cases. Overexpression of myc family oncogenes and mdr1 gene were 27/46 (59%) and 15/48 (31%), respectively. The results also showed that there was no significant correlation between p53 alteration and tumor size, metastasis, stage and relapse, but there was a significant correlation between overexpression of myc family oncogene and these factors. Overexpression of mdrl gene was detected in NSCLC, especially in adenocarcinoma, and was not associated with metastasis and stage of lung cancer. It was also found that aberration of both p53 and myc family oncogenes occurred in 19/30(63%) cases; the relapse rate was 76%. Both overexpression of mdrl and myc gene was 62%; the relapse rate was 83%.
p53, myc and mdrl genes in cooperation may be involved in the process of lung cancer, but prognostic determinant is myc gene overexpression.
研究原发性肺癌发生过程中多个基因的变化。
采用DNA/PCR测序、免疫组化及RT-PCR方法,对59例肺癌标本进行p53、myc癌基因家族及mdr1基因分析。
57例中有37例(65%)发现p53突变和/或蛋白蓄积。myc家族癌基因和mdr1基因的过表达分别为27/46(59%)和15/48(31%)。结果还显示,p53改变与肿瘤大小、转移、分期及复发之间无显著相关性,但myc家族癌基因过表达与这些因素之间存在显著相关性。mdr1基因过表达在非小细胞肺癌中被检测到,尤其是在腺癌中,且与肺癌的转移和分期无关。还发现19/30(63%)的病例中p53和myc家族癌基因均发生改变,复发率为76%。mdr1和myc基因均过表达的比例为62%,复发率为83%。
p53、myc和mdr1基因可能共同参与肺癌的发生过程,但预后决定因素是myc基因过表达。